.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Mary Jane's Medicinals is stocked at 140 licensed dispensaries across Colorado, Nevada, and Oklahoma, 138 of them in Colorado, with the deepest coverage in Denver, Colorado Springs, Durango, Aurora, and Boulder. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Mary Jane's Medicinals operated as a single-category brand in Topical, with Topical accounting for 100.0% of sales and posting a month-over-month change of 4.76% alongside a year-over-year decline of 24.30%. The brand’s average price rose 29.04% year over year to $48.49, while overall brand sales declined 24.30% year over year, indicating mix stability but demand elasticity pressure at higher price points. With Topical concentrated in Colorado and a current rank of 2 in the state-category, the combination of a 4.76% MoM uptick against a 24.30% YoY drop implies that recent sequential gains are not yet offsetting the longer-term contraction within a pure-play Topical strategy.
The shift toward higher pricing (+29.04% YoY) amid a single-category focus (100.0% Topical) suggests Mary Jane's Medicinals is leaning into premium positioning, but the 24.30% YoY sales decline paired with a 37.03% two-year drop signals a narrowing buyer base at current price tiers. Holding rank 2 in Colorado Topical while showing only a 4.76% MoM lift implies that maintaining placement now depends more on price-pack architecture and retention than on category expansion, and that further gains will likely require either elasticity-friendly price steps or innovation within Topical rather than diversification.
Competitive Landscape
Mary Jane's Medicinals sits at rank #2 in Colorado Topical for August 2026, unchanged year over year at #2, with a stable three-month position also at #2, while peak rank reached #2 in August 2026. In contrast, Escape Artists holds #1 now and also held #1 a year ago despite a -29.6% year-over-year sales change, and Highly Edible climbed from #4 to #3 alongside an 8.4% year-over-year sales increase; meanwhile, Nordic Goddess slipped from #3 to #4 as sales fell -36.3%. This combination—Mary Jane's Medicinals static at #2 while the #1 incumbent shows declining sales and a mid-pack contender moves up one rank—implies the brand’s rank trajectory is plateaued short-term, with headroom to challenge upward if it can convert competitor softness into share gains.
Notable Products
CBD/THC 1:3 Original Salve (75mg CBD, 225mg THC, 3.3oz) posted the steepest decline in August 2026 at -20.8% and sat at rank 6, while CBD/CBG/THC 5:1:5 Super Strength Nano Cream (220mg CBD, 44mg CBG, 220mg THC, 0.3oz) fell -22.9% to rank 7. In contrast, CBD/THC 1:1 Cloud 9 Bath Bomb (150mg CBD, 150mg THC, 5.5oz) surged +57.1% and reached rank 4, and CBD/THC 1:1 Super Strength Salve (500mg CBD, 500mg THC, 3.3oz) climbed +33.8% to a shared rank 2. With all top-10 SKUs concentrated in Topical formats, the mix points to a pivot toward higher-potency relief segments where 1:1 and multi-cannabinoid formulations are gaining share at the expense of legacy 1:3 salves.
CBD/CBG/THC 10:1:10 Ultra Strength Maxx 6000 Salve (3000mg CBD, 300mg CBG, 3000mg THC, 3oz) held rank 1 with +9.2% month over month and generated $46,531, while CBD/CBG/THC 5:1:5 Super Strength Nano Cream (1250mg CBD, 250mg CBG, 1250mg THC, 1.7oz) advanced +24.5% at rank 3. Meanwhile, CBD/CBG/CBC/THC 5:1:1:5 Super Strength Nano Salve (500mg CBD, 100mg CBG, 100mg CBC, 500mg THC, 3.3oz) declined -10.3% at rank 5 and the CBD/THC 1:3 Original Salve (6mg CBD, 18mg THC, 0.3oz) slipped -17.9% at rank 9. The pattern suggests Mary Jane's Medicinals is consolidating leadership around multi-cannabinoid, higher-ratio SKUs that defend top ranks even as lower-ratio variants contract.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
